Key cytokines derived from HRSC (e.g., CCL17/TARC, CCL22, IL9, IL13) were significantly lowly expressed in HL with HLA‐I+ compared to cases with HLA‐I− HRSCs (Supporting Information S1: Table 3). This evidence concerns the gene IL9 and Hodgkins lymphoma.